Osiris Therapeutics, Inc. Reports Fourth Quarter And Full Year 2014 Financial Results: For The Full Year, Revenue Increased 146% And Company Reports Record Revenue In Fourth Quarter

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today its financial results for the fourth quarter and full year ended December 31, 2014.

Help employers find you! Check out all the jobs and post your resume.

Back to news